SCHEMBL30441494

SCHEMBL30441494

CC(C)(C)OC(=O)C1CCN(C(=O)C2CCC(Nc3ccc(C4CCC(=O)NC4=O)cc3)CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 14/20 0.50
▸ DDB1 Q16531 13/20 0.50
▸ ALDH1A1 P00352 2/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GSPT1 P15170 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ PTPN6 P29350 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25502422 1.00 CRBN (0.50) CRBNDDB1ALDH1A1NPC1MAPT
SCHEMBL25502446 0.88 DDB1 (0.48) CRBNDDB1ALDH1A1NPC1MAPT
SCHEMBL30442388 0.87 CRBN (0.56) CRBNDDB1POLB
SCHEMBL25199468 0.86 CRBN (0.44) CRBNDDB1GSPT1POLBPTPN1
SCHEMBL30441406 0.86 CRBN (0.44) CRBNDDB1GSPT1POLBPTPN1
SCHEMBL25184855 0.86 CRBN (0.44) CRBNDDB1GSPT1POLBPTPN1
SCHEMBL25205685 0.85 CRBN (0.51) CRBNDDB1POLB
SCHEMBL25189125 0.85 DDB1 (0.47) CRBNDDB1
SCHEMBL25264962 0.85 DDB1 (0.47) CRBNDDB1
SCHEMBL25190965 0.85 CRBN (0.48) CRBNDDB1MAPTL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4430052-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF Nurix Therapeutics, Inc. (US) 2024-09-18 — — EP disclosed
WO-2023086399-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS, INC. (US) 2023-05-19 — — WO disclosed
Send feedback